Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study

Journal of Minimally Invasive Gynecology

Volumn 13, Issue 5, 2006, Pages 467-471

  Sabbah, Robert ^a   Desaulniers, Gilles ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Endometrial ablation; Menorrhagia; Myomas; NovaSure

Indexed keywords

ADULT; AMENORRHEA; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSMENORRHEA; ENDOMETRIUM ABLATION; ENDOMETRIUM POLYP; FEMALE; FOLLOW UP; HUMAN; HYSTEROSCOPY; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; METRORRHAGIA; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PREMENSTRUAL SYNDROME; QUESTIONNAIRE; SAFETY; SEDATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UTERUS MYOMA;

ADULT; CATHETER ABLATION; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEIOMYOMA; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UTERINE HEMORRHAGE; UTERINE NEOPLASMS;

EID: 33748140636     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2006.04.006     Document Type: Article

References (12)

1. Oehler M.K., and Rees M.C. Menorrhagia: an update. Acta Obstet Gynecol Scand 82 (2003) 405-422
2. Corrado M. Women's health in 1990 (1990), Market & Opinion Research International, London
3. Farquhar C., and Steiner C. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 99 (2002) 229-234
4. Keshavarz H., Hillis S., Kieke B., and Marchbanks P. Hysterectomy surveillance-United States, 1994-1999. MMWR 51 SS05 (2002) 1-8
5. Glasser M.H., and Zimmerman J.D. The HydroThermAblator system for management of menorrhagia in women with submucous myomas: 12- to 20-month follow-up. J Am Assoc Gynecol Laparosc 10 (2003) 521-527
6. Rosenbaum S.P., Fried M., and Munro M.G. Endometrial hydrothermablation: a comparison of short-term clinical effectiveness in patients with normal endometrial cavities and those with intracavitary pathology. J Minim Invasive Gynecol 12 (2005) 144-149
7. Gallinat A., and Nugent W. NovaSure Impedance-Controlled System for Endometrial Ablation. J Am Assoc Gynecol Laparosc 9 (2002) 283-289
8. Laberge P.Y., Sabbah R., Fortin C., and Gallinat A. Assessment and comparison of intraoperative and postoperative pain associated with NovaSure and ThermaChoice endometrial ablation systems. J Am Assoc Gynecol Laparosc 10 (2003) 223-232
9. Busund B., Erno L., Gronmark A., and Istre O. Endometrial ablation with NovaSure GEA: a pilot study. Acta obstetricia et gynecologica Scandinavica 82 (2003) 65-68
10. Gallinat A. NovaSure Impedance-Controlled System for Endometrial 2 trial Ablation: three-year follow-up on 107 patients. Am J Obstet Gynecol 191 (2004) 1585-1589
11. Abbott J., Hawe J., Hunter D., and Garry R. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertil Steril 80 (2003) 203-208
12. Cooper J., Gimpleson R., Laberge P., et al. A randomized, multicenter trial of safety and efficacy of the NovaSure System in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 9 (2002) 418-428